Tiziana Life Sciences Ltd

TLSANASDAQ · USD
1.11USD0.00 (+16.39%)
112

Tiziana Life Sciences Ltd (TLSA) Unusual Options Activity Today

TLSA options volume power reached 0.13x on the previous trading day. The highest reading was on the $2.5 CALL expiring 2026-10-16.

Read more

Checking TLSA unusual options activity helps you spot when traders are making outsized bets on Tiziana Life Sciences Ltd before the broader market catches on. Tiziana Life Sciences Ltd's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor TLSA unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching TLSA unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking TLSA unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and TLSA unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), a small molecule inhibitor of various cyclin-dependent kinases, tropomycin receptor kinases, and Src family kinases controlling cell growth and malignant progression of cancer; and anti-Interleukin 6 receptor (IL6R) mAb (TZLS-501), a fully human monoclonal antibody for the treatment of IL6-induced inflammation and to treat COVID-19 patients.

The company was incorporated in 1998 and is headquatered in London, the United Kingdom.

Catalysts rarely arrive without a footprint, and TLSA unusual options activity is often where that footprint shows up first. Our scanner tracks Tiziana Life Sciences Ltd's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at TLSA unusual options volume on the call side or chasing put sweeps, Tiziana Life Sciences Ltd's unusual options flow today is one click away, so put it on your radar before the headlines hit.

2026-12-18
Calls
2.500.100.150.13184%262,2631.15%
5.00—0.150.15272%0720.00%
7.50—4.304.301,000%040.00%
Puts
2.50—4.404.401,000%05600.00%
5.001.506.504.00274%00—
7.504.009.006.50324%00—

As of September 30, 2026

Spot unusual options activity before it moves

Track TLSA options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.

Start your 14-day free trial